187 related articles for article (PubMed ID: 34379349)
1. Implantable cardioverter-defibrillator in patients with spontaneous coronary artery dissection presenting with sudden cardiac arrest.
Garg J; Shah K; Shah S; Turagam MK; Natale A; Lakkireddy D
J Cardiovasc Electrophysiol; 2021 Sep; 32(9):2595-2600. PubMed ID: 34379349
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of patients with spontaneous coronary artery dissection who suffered sudden cardiac arrest.
Phan D; Clare R; Duan L; Kim C; Moore N; Lee MS
J Interv Card Electrophysiol; 2021 Jan; 60(1):77-83. PubMed ID: 32048115
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter-defibrillator therapy in device recipients who survived a cardiac arrest associated with a reversible cause.
Gupta A; Pasupula DK; Bhonsale A; Kancharla K; Wang NC; Adelstein E; Jain S; Saba S
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1413-1417. PubMed ID: 30015993
[TBL] [Abstract][Full Text] [Related]
4. Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE-CMR.
van der Lingen ACJ; Becker MAJ; Kemme MJB; Rijnierse MT; Spoormans EM; Timmer SAJ; van Rossum AC; van Halm VP; Germans T; Allaart CP
J Am Heart Assoc; 2021 Apr; 10(8):e019101. PubMed ID: 33821672
[TBL] [Abstract][Full Text] [Related]
5. Recurrent ventricular arrhythmias and mortality in cardiac arrest survivors with a reversible cause with and without an implantable cardioverter defibrillator: A systematic review.
van der Lingen ACJ; Woudstra J; Becker MAJ; Mol MAE; van Rossum AC; Rijnierse MT; Allaart CP
Resuscitation; 2022 Apr; 173():76-90. PubMed ID: 35227821
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous implantable cardioverter defibrillator for spontaneous coronary artery dissection with ventricular fibrillation: A report of two cases.
Ueda T; Osada J; Kowase S; Asano S; Yumoto K
J Cardiol Cases; 2022 Oct; 26(4):260-263. PubMed ID: 36187318
[TBL] [Abstract][Full Text] [Related]
7. In-hospital and long-term outcomes among patients with spontaneous coronary artery dissection presenting with ventricular tachycardia/fibrillation.
Cheung CC; Starovoytov A; Parsa A; Andrade JG; Krahn AD; Bennett M; Saw J
Heart Rhythm; 2020 Nov; 17(11):1864-1869. PubMed ID: 32590153
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients.
Blom LJ; Visser M; Christiaans I; Scholten MF; Bootsma M; van den Berg MP; Yap SC; van der Heijden JF; Doevendans PA; Loh P; Postema PG; Barge-Schaapsveld DQ; Hofman N; Volders PGA; Wilde AA; Hassink RJ
Europace; 2019 Oct; 21(10):1519-1526. PubMed ID: 31114860
[TBL] [Abstract][Full Text] [Related]
10. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
Silka MJ; Kron J; Dunnigan A; Dick M
Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
[TBL] [Abstract][Full Text] [Related]
11. Spectrum and Outcome of Patients Who Have Undergone Implantation of an Implantable Cardioverter Defibrillator After Aborted-Sudden Cardiac Arrest.
Extramiana F; Stordeur B; Furioli V; Gandjbakhch E; Lellouche N; Algalarrondo V; Varlet E; Messali A; Marijon E; Leenhardt A;
Am J Cardiol; 2018 Jan; 121(2):149-155. PubMed ID: 29153773
[TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators.
Sroubek J; Matos J; Locke A; Kaplinskiy V; Levine YC; Shen C; Buxton AE
Heart Rhythm; 2021 Jan; 18(1):71-78. PubMed ID: 32866691
[TBL] [Abstract][Full Text] [Related]
13. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.
Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ;
Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.
van der Werf C; Lieve KV; Bos JM; Lane CM; Denjoy I; Roses-Noguer F; Aiba T; Wada Y; Ingles J; Leren IS; Rudic B; Schwartz PJ; Maltret A; Sacher F; Skinner JR; Krahn AD; Roston TM; Tfelt-Hansen J; Swan H; Robyns T; Ohno S; Roberts JD; van den Berg MP; Kammeraad JA; Probst V; Kannankeril PJ; Blom NA; Behr ER; Borggrefe M; Haugaa KH; Semsarian C; Horie M; Shimizu W; Till JA; Leenhardt A; Ackerman MJ; Wilde AA
Eur Heart J; 2019 Sep; 40(35):2953-2961. PubMed ID: 31145795
[TBL] [Abstract][Full Text] [Related]
16. Implications of Initial Recorded Rhythm on Cardioverter-Defibrillator Insertion and Subsequent All-Cause Mortality in Sudden Cardiac Arrest Survivors.
Polsinelli VB; Wang NC; Kancharla K; Bhonsale A; Jain SK; Saba S
Am J Cardiol; 2019 Sep; 124(5):709-714. PubMed ID: 31279406
[TBL] [Abstract][Full Text] [Related]
17. Impact of a Chronic Total Coronary Occlusion on the Incidence of Appropriate Implantable Cardioverter-Defibrillator Shocks and Mortality: A Substudy of the Dutch Outcome in ICD Therapy (DO-IT)) Registry.
van Veelen A; Verstraelen TE; Somsen YBO; Elias J; van Dongen IM; Delnoy PPHM; Scholten MF; Boersma LVA; Maass AH; Strikwerda S; Firouzi M; Allaart CP; Vernooy K; Grauss RW; Tukkie R; Knaapen P; Zwinderman AH; Dijkgraaf MGW; Claessen BEPM; van Barreveld M; Wilde AAM; Henriques JPS;
J Am Heart Assoc; 2024 Apr; 13(8):e032033. PubMed ID: 38591264
[TBL] [Abstract][Full Text] [Related]
18. Physical function, psychological adjustment, and self-efficacy following sudden cardiac arrest and an initial implantable cardioverter defibrillator (ICD) in a social cognitive theory intervention: secondary analysis of a randomized control trial.
Dougherty CM; Liberato ACS; Streur MM; Burr RL; Kwan KY; Zheng T; Auld JP; Thompson EA
BMC Cardiovasc Disord; 2022 Aug; 22(1):369. PubMed ID: 35948889
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter-defibrillator therapy after resuscitation from cardiac arrest in vasospastic angina: A retrospective study.
Tateishi K; Kondo Y; Saito Y; Kitahara H; Fukushima K; Takahashi H; Yamashita D; Ohashi K; Suzuki K; Hashimoto O; Sakai Y; Kobayashi Y
PLoS One; 2022; 17(10):e0277034. PubMed ID: 36315563
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
